Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure - OPTIME-CHF

Description:

OPTIME-CHF was a randomized trial of short-term intravenous (IV) milrinone versus placebo in patients with decompensated systolic heart failure for whom inotropic therapy was not felt to be mandatory.